In the News

All of Us CEO Josh Denny weighs in on the potential of artificial intelligence to gain actionable insights from genomic data and advance precision medicine.

All of Us partner Scripps Research has recently launched a new pilot project to collect more longitudinal health data from participants through wearable devices.

STAT reports on how the technology platform underpinning the All of Us Researcher Workbench stands to make data and tools accessible to broader audiences to spur new discoveries.

Intel joins the NIH All of Us Research Program in its historic effort to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench.

Participants of the All of Us Research Program who enrolled at the UW Health site will soon receive their genetic results from the biosamples they donated starting in 2018. The results may reveal how their DNA might affect their body’s response to certain types of medicine and the genetic variants associated with increased risk of specific diseases.

Angela Williams and Chris Crawford, research study navigators at the University of Alabama at Birmingham, discuss how the All of Us Research Program will benefit underrepresented populations and improve health care for future generations. They also explain their reasons for joining the All of Us team and what motivates them to propel All of Us forward.

NIH Director Dr. Francis Collins previews early steps in the Precision Medicine Initiative in an audio interview with Stephen Morrissey, managing editor of the New England Journal of Medicine.

Essentia Health was selected as an enrollment partner for the All of Us Research Program, to enroll participants from rural communities in northern Minnesota, Wisconsin, and North Dakota in a COVID-19 research study.

Vanderbilt Health is leveraging large swaths of clinical and genetic data to create personalized health care technologies. The large swaths of data that make these technologies possible come from the All of Us Research Program, for which Vanderbilt serves as a major hub. “All of Us is really an exciting project built on a lot of converging elements and technologies that have made a scale of projects in biomedical sciences that has never been possible before,” said Josh Denny, vice president of personalized medicine at Vanderbilt and CEO of All of Us.

The LA Times reports on the All of Us Research Program's rapid pivot to COVID-19 research, calling the efforts a "potential bright spot" in the landscape of pandemic research.

All of Us Research Program CEO Dr. Josh Denny joins the Government CIO podcast to discuss the importance of electronic health records and the program’s work to support COVID-19 research.

All of Us Research Program CEO Dr. Josh Denny joins the Government CIO podcast to discuss the importance of electronic health records and the program's work to support COVID-19 research.